IDEXX Laboratories, Inc. Financials

Market Capitalization $35.40 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	41.65
Forward PE	36.15
Price to Sales TTM	$9.21
Price to Book MRQ	$21.92
Enterprise to Revenue	9.39
Enterprise to EBITDA	27.78

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	22.53%
Operating Margin	37.46%
Return on Assets TTM	22.79%
Return on Equity TTM	59.42%

Income Statement

Revenue TTM	$3,844,816,896
Revenue per Share TTM	$46.45
Quarterly Revenue Growth	6.60%
Gross Profit TTM	$2,334,434,048
EBITDA	$1,252,051,000
Net Income to Common TTM	$866,238,976
Diluted EPS TTM	$10.38
Quarterly Earnings Growth YoY	9.70%

Balance Sheet

Total Cash MRQ	$308,636,000
Total Cash per Share MRQ	$3.77
Total Debt MRQ	$
Total Debt to Equity MRQ	61.70
Current Ratio MRQ	1.42
Book Value per Share MRQ	$19.72

Cash Flow

Operating Cash Flow TTM	$916,827,008
Levered Free Cash Flow TTM	$792,041,600

IDXX Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	81,884,704
Float Shares	80,972,469
Avg 10 Volume	591,750
Avg 30 Volume	None
Shares Short	1,495,773
Short Ratio	2.57
Short % of Shares	2.35%
% Held by Insiders	0.94%
% Held by Institutions	95.08%

Stock Price Summary

Beta	1.36
Fifty Two Week Low	$398.50
Fifty Two Week High	$583.39
Fifty Two Week Change	-22.22%
Day 50 MA	$424.43
Day 200 MA	$470.54

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2015-06-16